The NKG2A immune checkpoint a new direction in cancer immunotherapy

The NKG2A immune checkpoint — a new direction in cancer immunotherapy

13:41 EST 1 Mar 2019 | Nature Publishing

Original Article: The NKG2A immune checkpoint — a new direction in cancer immunotherapy

More From BioPortfolio on "The NKG2A immune checkpoint — a new direction in cancer immunotherapy"